Skip to main content
Skip to main menu
Skip to user menu
Login
|
Employer Login
News
Clinical Research
Finance
Covid-19
See all news
Jobs
Search jobs
Job alerts
Hotbeds
Biotech Bay
Genetown
Biotech Beach
BioMidwest
Pharm Country
See all regions
Career Resources
Newsletters
Company Profiles
Advertise
Biotech Bay
Biotech Beach
BioCapital
BioMidwest
Bio NC
BioForest
Genetown
Best Places to Work
Pharm Country
Lone Star Bio
NextGen Bio
The Home of the Life Sciences Industry
Biosimilar Sales Up as Insurers Begin Dropping Humira Coverage
Policy changes by health insurance companies will likely determine which Humira biosimilars rise to the top.
Biopharma Layoff Tracker 2024: Tessera, BenevolentAI, Pfizer and More Cut Staff
Follow along as BioSpace keeps you up-to-date on the latest pharma and biotech layoffs.
Novartis Beats Q1 Expectations, Raises 2024 Outlook on Strong Drug Sales
Incyte Inks $750M Deal to Buy Escient and Skin Disease Drug Candidates
Sanofi’s $3.7B Principia Buy Starts to Pay Off with Phase III Rilzabrutinib Win
Search Life Sciences Jobs:
Keywords
Location
More Top Stories
ImmunityBio Wins FDA Approval for First IL-15 Superagonist for NMIBC
Supreme Court Denies Vanda’s Petition in Hetlioz Patent Case Agains...
FDA Rejects Abeona’s Epidermolysis Bullosa Cell Therapy, Asks for C...
FDA Rejects Abeona’s Gene Therapy, Approves ImmunityBio’s Bladder C...
Incyte Breaks Mid-April M&A Lull With Escient Purchase
View more news
Now Hiring
>
>
View all Featured Employers
Careers
Bioversity Program Preps Grads for Early-Career Life Science Roles
How to Deal With Layoff-Related Stress
Career Coach: How to Look Professional in Virtual Meetings
In case you missed it
4/23/2024
Novartis Beats Q1 Expectations, Raises 2024 Outlook on Strong Drug Sales
4/23/2024
Incyte Inks $750M Deal to Buy Escient and Skin Disease Drug Candidates
4/23/2024
Sanofi’s $3.7B Principia Buy Starts to Pay Off with Phase III Rilzabrutinib Win
4/23/2024
ImmunityBio Wins FDA Approval for First IL-15 Superagonist for NMIBC
4/23/2024
FDA Rejects Abeona’s Epidermolysis Bullosa Cell Therapy, Asks for CMC Data
Hotbeds
>
>
View all Hotbeds
Clinical Research
4/23/2024
Sanofi’s $3.7B Principia Buy Starts to Pay Off with Phase III Rilzabrutinib Win
4/23/2024
ImmunityBio Wins FDA Approval for First IL-15 Superagonist for NMIBC
4/23/2024
FDA Rejects Abeona’s Gene Therapy, Approves ImmunityBio’s Bladder Cancer Treatment
4/22/2024
23andMe, Innate Pharma Tap Antibodies to Target NK Cells for Cancer
Finance
Biopharma Layoff Tracker 2024: Tessera, BenevolentAI, Pfizer and More Cut Staff
Novartis Beats Q1 Expectations, Raises 2024 Outlook on Strong Drug Sales
Covid-19
Biosimilar Sales Up as Insurers Begin Dropping Humira Coverage
Biopharma Layoff Tracker 2024: Tessera, BenevolentAI, Pfizer and More Cut Staff
2024 Employment Outlook Report
Recruiting with AI: Trends and Challenges in Life Sciences
U.S. Life Sciences Salary Report
Best Places to Work in Biopharma